# Biomat USA, Inc – FDA Inspection, Feb 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/82636e11-2464-4a63-a53b-6e722a714f41
Source feed: FDA_Inspections

> FDA inspection 1005674 of Biomat USA, Inc, February 15, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005674
- Company Name: Biomat USA, Inc
- Inspection Date: 2017-02-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1253778 - 2024-10-25
- FDA Inspection 912526 - 2015-02-04
- [FDA Inspection 808445 - 2012-12-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b998c594-4649-4da5-bfce-04ec5a667ef1)
- FDA Inspection 706602 - 2011-01-12
- [FDA Inspection 562135 - 2009-02-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b9135d63-2b5e-4bc9-b384-4c5d58b764f1)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/travis-r-hunt/a10b358d-80ac-44af-9c9e-761660db1a53)

Company: https://www.keypedia.com/companies/biomat-usa-inc/b6273141-77b1-4ec0-948b-501e4d7ef2b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d